Simplex Trading’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-57
Closed -$17K – 8359
2019
Q3
$17K Buy
57
+42
+280% +$118 ﹤0.01% 5939
2019
Q2
$3K Sell
15
-247
-94% -$738 ﹤0.01% 6705
2019
Q1
$98K Buy
262
+152
+138% +$569 ﹤0.01% 4348
2018
Q4
$39K Buy
110
+29
+36% +$126 ﹤0.01% 4779
2018
Q3
$46K Buy
81
+79
+3,950% +$452 ﹤0.01% 5257
2018
Q2
$1K Buy
+2
New +$10 ﹤0.01% 7250
2017
Q4
– Sell
-22
Closed -$1K – 7072
2017
Q3
$1K Buy
+22
New +$114 ﹤0.01% 5686
2017
Q2
– Sell
-410
Closed -$5K – 7168
2017
Q1
$5K Buy
410
+156
+61% +$1.5K ﹤0.01% 4672
2016
Q4
$50K Buy
254
+81
+47% +$762 ﹤0.01% 2170
2016
Q3
$26K Buy
+173
New +$1.45K ﹤0.01% 2727

Simplex Trading's FOMX Position: Q1 2020 in Review

Simplex Trading sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 38,420 shares — an estimated $127K sold.

Simplex Trading first reported a position in FOMX in Q1 2017 and held it in 10 quarters. The position peaked at $127K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Simplex Trading reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Simplex Trading sold 38,420 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $127K.
  • Simplex Trading first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2017 and held it in 10 quarters.
  • Simplex Trading's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $127K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.